SupplementDrug
Resveratrol clinical trials
Also written resVida and BIA 6-512.
- studies test it
- 134
- open now
- 9
- in phase 3
- 11
- first study started
- 2004
Keep track of what changes. Save the Resveratrol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Other names
Combined with it in one product
Studies by the year they started
134 studies that test it; most in 2011 (13)
| Year | Studies |
|---|---|
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 7 |
| 2010 | 5 |
| 2011 | 13 |
| 2012 | 12 |
| 2013 | 9 |
| 2014 | 9 |
| 2015 | 11 |
| 2016 | 9 |
| 2017 | 2 |
| 2018 | 9 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 4
- Phase 1
- 22
- Phase 2
- 32
- Phase 3
- 11
- Phase 4
- 4
- No phase
- 68
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 125
Northumbria University (9) · Bial - Portela C S.A. (7) · Maastricht University Medical Center (6) · University of Aarhus (5) · National Cancer Institute (NCI) (4) · Khyber Medical University Peshawar (3) · University of Florida (3) · InCor Heart Institute (3)
Often tested with
Tested in the same studies.
Curcumin (4) · Urtica dioica (2) · Nicotinamide-beta-riboside (2) · Ascorbic Acid (2) · Thioctic Acid (2) · Chenodeoxycholic Acid (1) · Atorvastatin (1) · Quercetin (1)
Studies
Open first, then newest update. How each study uses Resveratrol is read from its arms, and is right about nine times in ten.
Testing it · 134
- Serum Endogenous Estrogens, Estrogen Receptors, and Sirtuin-1 and -3 After Resveratrol SupplementationRecruitingNot applicableInCor Heart InstituteNCT07865377Written as Trans-resveratrol, 1000 mg daily for 90 days
- RESvEraTrol in Parkinson's Disease (RESET)RecruitingPhase 2Georgetown UniversityNCT07592767Written as Trans-Resveratrol
- Strength Training and ResveratrolRecruitingNot applicableTexas Tech UniversityNCT06585865Written as Resveratrol 500 mg oral once daily.
- Mucoadhesive Modified-Release Formulations for the Topical Treatment of Symptomatic Oral Lichen PlanusRecruitingPhase 2University of PalermoNCT07100613Written as Clobetasol + Resveratrol Patch
- Comparative Efficacy of Resveratrol 1 % Gel and Trichloroacetic Acid 20% in Treatment of Melasma: A Split-face StudyNot yet recruitingNot applicableAssiut UniversityNCT07060157Written as resveratrol 1 % gel
- Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.RecruitingPhase 3Al-Mustansiriyah UniversityNCT06882564Written as resveratrol mouthwash
- Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1RecruitingEarly Phase 1Augusta UniversityNCT04449198Written as Resveratrol
- Effects of Resveratrol Supplementation on Oocyte QualityNot yet recruitingNot applicableCentro Hospitalar e Universitário de Coimbra, E.P.E.NCT06235294Written as Resveratrol
- The Effects of Resveratrol on Sirtuins and Apoptosis BiomarkersRecruitingNot applicableInCor Heart InstituteNCT05808387Written as Resveratrol
- Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWICompletedNot applicableUniversity of Alabama at BirminghamNCT05377242Written as Resveratrol
- Resveratrol for Endothelial Dysfunction and Metabolic Control in Type 2 DiabetesCompletedNot applicableUniversitas SriwijayaNCT07569744Written as Resveratrol
- Resveratrol for the Prevention of Bone Loss in Postmenopausal WomenCompletedNot applicableUniversity of DelawareNCT06250283Written as Resveratrol
- Resveratrol in Knee OsteoarthritisCompletedPhase 3Assistance Publique - Hôpitaux de ParisNCT02905799Written as oral resveratrol
- Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5CompletedPhase 2Institut National de la Santé Et de la Recherche Médicale, FranceNCT02314208Written as Resveratrol
- A Study to Evaluate the Safety and Efficacy of RQC for AMDCompletedPhase 2Paul A Knepper, MD PhDNCT05062486Written as Resveratrol, Quercetin, Curcumin (RQC)
- Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic FibrosisCompletedEarly Phase 1Virginia Commonwealth UniversityNCT04166396Written as Resveratrol
- Resveratrol Stimulates Insulin Sensitivity in Subjects With Obesity and Insulin ResistanceCompletedNot applicableInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranNCT06961279Written as Resveratrol
- Study of High-Dose Resveratrol in Patients With Stable Ischemic Heart DiseaseCompletedNot applicableS.LAB (SOLOWAYS)NCT06914934Written as High-dose resveratrol 500 mg/day
- Short Interval Resveratrol Trial in Cardiovascular SurgeryActive, not recruitingNot applicableMaineHealthNCT03762096Written as Trans-resveratrol
- Metabolism of Bioactive Dietary Polyphenol Preparation (BDPP)CompletedPhase 1Icahn School of Medicine at Mount SinaiNCT04421079Written as Trans-resveratrol
See all 134 studies that test Resveratrol →
Given in every arm · 1 — Resveratrol is usual care beside what is tested
As the comparator · 3 — what is tested is compared with Resveratrol
- Pilot Study to Evaluate the Plasma Profile of RevifastCompletedNot applicableBernard FiorettiNCT04258306Written as pure resveratrol
- Resveratrol With or Without Piperine to Enhance Plasma Levels of ResveratrolCompletedNot applicableUniversity of Wisconsin, MadisonNCT01324089Written as Resveratrol
- Pharmacokinetics of Resveratrol Comprising ProductsCompletedNot applicableFruitura Bioscience Ltd.NCT01747252Written as Resveratrol
Codes
What other systems call Resveratrol · ClinicalTrials.gg INT006657
- MeSH (NLM) D000077185ResveratrolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) Q369O8926LRESVERATROLConfirmed FDA, NLM, Wikidata
- RxNorm 1000492Confirmed FDA, Wikidata
- Wikidata Q407329resveratrolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1215ResveratrolOne source FDA
- DrugBank DB02709One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077185 | Resveratrol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | Q369O8926L | RESVERATROL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1000492 | — | Confirmed FDA, Wikidata |
| Wikidata | Q407329 | resveratrol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1215 | Resveratrol | One source FDA |
| DrugBank | DB02709 | — | One source Wikidata |
Also registered as resveratrol, (z)- (UNII AUA0K06FSB).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.